Public Employees Retirement System of Ohio Makes New $1.77 Million Investment in Tempus AI, Inc. $TEM

Public Employees Retirement System of Ohio acquired a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 30,639 shares of the company's stock, valued at approximately $1,775,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. JPL Wealth Management LLC bought a new stake in Tempus AI in the third quarter valued at approximately $26,000. Los Angeles Capital Management LLC purchased a new position in shares of Tempus AI in the fourth quarter worth $27,000. Harvest Fund Management Co. Ltd purchased a new position in shares of Tempus AI in the third quarter worth $38,000. Danske Bank A S bought a new stake in Tempus AI during the 3rd quarter valued at $48,000. Finally, Sunbelt Securities Inc. purchased a new stake in Tempus AI during the 3rd quarter valued at $52,000. Institutional investors own 24.22% of the company's stock.

Insider Buying and Selling at Tempus AI

In other news, CEO Ryan Fukushima sold 14,286 shares of the company's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $70.00, for a total transaction of $1,000,020.00. Following the transaction, the chief executive officer owned 47,420 shares of the company's stock, valued at $3,319,400. This represents a 23.15% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Nadja West sold 3,000 shares of the company's stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $69.00, for a total transaction of $207,000.00. Following the sale, the director owned 31,981 shares in the company, valued at $2,206,689. The trade was a 8.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,043,988 shares of company stock valued at $56,963,417 in the last three months. 24.26% of the stock is owned by corporate insiders.

Tempus AI Stock Performance

Shares of TEM opened at $64.62 on Monday. Tempus AI, Inc. has a 52 week low of $40.77 and a 52 week high of $104.32. The company has a quick ratio of 3.16, a current ratio of 3.30 and a debt-to-equity ratio of 3.06. The stock has a market cap of $11.66 billion, a P/E ratio of -44.87 and a beta of 3.72. The business's 50 day moving average price is $55.77 and its 200-day moving average price is $52.13.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its earnings results on Thursday, July 30th. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.14) by $0.10. Tempus AI had a negative return on equity of 50.28% and a negative net margin of 17.77%.The business had revenue of $382.49 million for the quarter, compared to the consensus estimate of $379.69 million. During the same period in the previous year, the company posted ($0.22) earnings per share. The company's revenue for the quarter was up 21.6% compared to the same quarter last year. Equities research analysts anticipate that Tempus AI, Inc. will post -1.38 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have issued reports on TEM. Weiss Ratings cut shares of Tempus AI from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Thursday, August 27th. TD Cowen reiterated a "buy" rating on shares of Tempus AI in a report on Wednesday, July 15th. Guggenheim raised their target price on Tempus AI from $60.00 to $65.00 and gave the stock a "buy" rating in a research note on Thursday, July 16th. Freedom Capital raised Tempus AI to a "hold" rating in a research report on Tuesday, June 30th. Finally, Wall Street Zen raised Tempus AI from a "sell" rating to a "hold" rating in a research note on Saturday, July 25th. Eleven investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $68.93.

Tempus AI Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company's core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source